By India Blooms News Service Sep 06, 2022
New Delhi: Bharat Biotechs needle-free intranasal vaccine against Covid-19 has gained emergency use approval in India Union health minister Mansukh Mandaviya confirmed on Tuesday.
The Minister said the step will further strengthen Indias collective fight against the pandemic.
The vaccine could be delivered through naval route.
This step will further strengthen our collective fight against the pandemic. India has harnessed its science, RD, and human resources in the fight against COVID-19 under PM @NarendraModi Jis leadership. With the science-driven approach Sabka Prayas, we will defeat COVID-19.
Dr Mansukh Mandaviya (@mansukhmandviya) September 6, 2022
Big Boost to Indias Fight Against COVID-19! Bharat Biotechs ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation, the Minister tweeted.
Big Boost to Indias Fight Against COVID-19! Bharat Biotechs ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.
Dr Mansukh Mandaviya (@mansukhmandviya) September 6, 2022
This step will further strengthen our collective fight against the pandemic. India has harnessed its science, RD, and human resources in the fight against COVID-19 under PM @NarendraModi Jis leadership. With the science-driven approach Sabka Prayas, we will defeat COVID-19, he said.
India reported 4,417 new Covid-19 cases while the toll went up by 23 in the last 24 hours, the Union Health Ministry said Tuesday.
In the same span of time, 6,032 Covid-19 patients have recovered from across the country.
The active cases, which now stand at 52,336, forms 0.12% of the total number of infections.
The recovery rate now stands at 98.69%.
Under the national vaccination drive, 213.72 crore anti-Covid vaccine doses have been administered in the country.